These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2433386)

  • 21. Monoclonal antibodies against Ogawa specific & Ogawa-Inaba common antigenic determinants of Vibrio cholerae O1 & their diagnostic utility.
    Ramamurthy T; Garg S; Nair GB
    Indian J Med Res; 1995 Jan; 101():10-2. PubMed ID: 7533744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of methyl alpha-glycosides of some higher oligosaccharide fragments of the O-antigen of Vibrio cholerae O1, serotype Inaba and Ogawa.
    Zhang J; Kovác P
    Carbohydr Res; 1997 May; 300(4):329-39. PubMed ID: 9210300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the lipopolysaccharide from Vibrio cholerae 395 (Ogawa).
    Kabir S
    Infect Immun; 1982 Dec; 38(3):1263-72. PubMed ID: 7152669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A bioserogroup of marine vibrios possessing somatic antigen factors in common with Vibrio cholerae O1.
    Shimada T; Sakazaki R; Oue M
    J Appl Bacteriol; 1987 May; 62(5):453-6. PubMed ID: 3610890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Occurrence of 2-O-methyl-N-(3-deoxy-L-glycero-tetronyl)-D-perosamine (4-amino-4,6-dideoxy-D-manno-pyranose) in lipopolysaccharide from Ogawa but not from Inaba O forms of O1 Vibrio cholerae.
    Hisatsune K; Kondo S; Isshiki Y; Iguchi T; Haishima Y
    Biochem Biophys Res Commun; 1993 Jan; 190(1):302-7. PubMed ID: 8422256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Choleragen-anatoxin chemical cholera vaccine enriched with Ogawa O-antigen].
    Dzhaparidze MN; Nikitina GP; Kulikova VL; Popov AA; Naumov AV
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Apr; (4):70-4. PubMed ID: 6204471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolation and characterization of protective anti-LPS nanobody against V. cholerae O1 recognizing Inaba and Ogawa serotypes.
    Ebrahimizadeh W; Mousavi Gargari S; Rajabibazl M; Safaee Ardekani L; Zare H; Bakherad H
    Appl Microbiol Biotechnol; 2013 May; 97(10):4457-66. PubMed ID: 23135228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunochemical properties of Vibrio cholerae LPS.
    Bukovský M; Ciznár I
    Folia Microbiol (Praha); 1993; 38(6):519-23. PubMed ID: 7512065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens.
    Lebens M; Karlsson SL; Källgård S; Blomquist M; Ekman A; Nygren E; Holmgren J
    Vaccine; 2011 Oct; 29(43):7505-13. PubMed ID: 21807059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Production and characterisation of monoclonal antibodies to outer-membrane-protein antigens of Vibrio cholerae O1.
    Kabir S
    J Med Microbiol; 1991 Mar; 34(3):167-73. PubMed ID: 1901361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Some immunochemical and immunobiological properties of Vibrio cholerae serovar 0139 capsule antigen].
    Fedorova VA; Devdariani ZL; Gromova OV; Livanova LF
    Mol Gen Mikrobiol Virusol; 1997; (3):18-20. PubMed ID: 9297105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Aspects of Vibrio cholerae lipopolysaccharide].
    Lobanov VV; Sukhar' VV
    Zh Mikrobiol Epidemiol Immunobiol; 2002; (2):102-7. PubMed ID: 12043141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of protective immunity by synthetic Vibrio cholerae hexasaccharide derived from V. cholerae O1 Ogawa lipopolysaccharide bound to a protein carrier.
    Chernyak A; Kondo S; Wade TK; Meeks MD; Alzari PM; Fournier JM; Taylor RK; Kovác P; Wade WF
    J Infect Dis; 2002 Apr; 185(7):950-62. PubMed ID: 11920320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A monoclonal antibody-based study of the antigenic interrelations of typical and R forms of Vibrio cholerae].
    Alekseeva LP; Cherepakhina IIa; Sal'nikova OI; Burlakova OS
    Zh Mikrobiol Epidemiol Immunobiol; 1998; (4):9-12. PubMed ID: 9783389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterizing lipopolysaccharide and core lipid A mutant O1 and O139 Vibrio cholerae strains for adherence properties on mucus-producing cell line HT29-Rev MTX and virulence in mice.
    Schild S; Lamprecht AK; Fourestier C; Lauriano CM; Klose KE; Reidl J
    Int J Med Microbiol; 2005 Aug; 295(4):243-51. PubMed ID: 16128399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on the partial structure of the O-antigen of Vibrio cholera, Inaba 569 B.
    Sen AK; Mukherjee AK; Guhathakurta B; Dutta A; Sasmal D
    Carbohydr Res; 1980 Nov; 86(1):113-21. PubMed ID: 7438130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Syntheses of the L-manno and some other analogs of the terminal determinants of the O-PS of Vibrio cholerae O:1.
    Poirot E; Zhang X; Whittaker NF; Kovác P
    Carbohydr Res; 2001 Jan; 330(1):7-20. PubMed ID: 11217964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regions of the cloned Vibrio cholerae rfb genes needed to determine the Ogawa form of the O-antigen.
    Morona R; Matthews MS; Morona JK; Brown MH
    Mol Gen Genet; 1990 Dec; 224(3):405-12. PubMed ID: 1702506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different types of monoclonal antibodies to Ogawa-specific and group-specific antigens of Vibrio cholerae O1.
    Ito T; Yokota T
    J Clin Microbiol; 1987 Dec; 25(12):2289-95. PubMed ID: 2448333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation and immunogenicity of a bivalent cell-surface protein-polysaccharide conjugate of Vibrio cholerae.
    Kabir S
    J Med Microbiol; 1987 Feb; 23(1):9-18. PubMed ID: 3820275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.